Implementation of sentinel node biopsy in breast cancer patients in the Netherlands

European Journal of Cancer

Volumn 44, Issue 5, 2008, Pages 683-691

  Ho, Vincent K Y ^a   van der Heiden van der Loo, Margriet ^a   Rutgers, Emiel J Th ^b   van Diest, Paul J ^c   Hobbelink, Monique G G ^c   Tjan Heijnen, Vivianne C G ^d   Dirx, Miranda J M ^e   Reedijk, Ardine M J ^f   van Dijck, Jos A A M ^g,h   van de Poll Franse, Lonneke V ⁱ   Schaapveld, Michael ^j   Peeters, Petra H M ^c  

^a Department of Registration and Research   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Maastricht UMC+ Comprehensive Cancer Centre   (Netherlands)

^f Integraal Kankercentrum Rotterdam   (Netherlands)

^g Integraal Kankercentrum Oost   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ The Netherlands   (Netherlands)

^j Integraal Kankercentrum Noord Nederland   (Netherlands)

more..

Author keywords

Axillary lymph node dissection; Breast cancer; Breast conserving surgery; Implementation; Mastectomy; Sentinel node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER SURGERY; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NETHERLANDS; SENTINEL LYMPH NODE BIOPSY;

EID: 40849151833     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.01.027     Document Type: Article

References (49)

1. Krag D.N., Weaver D.L., Alex J.C., and Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2 (1993) 335-340
2. Giuliano A.E., Kirgan D.M., Guenther J.M., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-398
3. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
4. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
5. Goyal A., and Mansel R.E. Current status of sentinel lymph node biopsy in solid malignancies. World J Surg Oncol 2 (2004) 9
6. Liljegren G., and Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 33 (1997) 193-199
7. Ivens D., Hoe A.L., Podd T.J., Hamilton C.R., Taylor I., and Royle G.T. Assessment of morbidity from complete axillary dissection. Br J Cancer 66 (1992) 136-138
8. Erickson V.S., Pearson M.L., Ganz P.A., Adams J., and Kahn K.L. Arm edema in breast cancer patients. J Natl Cancer Inst 93 (2001) 96-111
9. Petrek J.A., and Meelan M.C. Incidence of breast cancer-related lymphedema. Cancer 83 (1998) 2776-2781
10. Voogd A.C., Ververs J.M., Vingerhoets A.J., Roumen R.M., Coebergh J.W., and Crommelin M.A. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 90 (2003) 76-81
11. Ververs J.M., Roumen R.M., Vingerhoets A.J., et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37 (2001) 991-999
12. Giuliano A.E., Haigh P.I., Brennan M.B., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18 (2000) 2553-2559
13. Sener S.F., Winchester D.J., Martz C.H., et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92 (2001) 748-752
14. Burak W.E., Hollenbeck S.T., Zervos E.E., Hock K.L., Kemp L.C., and Young D.C. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183 (2002) 23-27
15. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 (2006) 599-609
16. van Diest P.J., Torrenga H., Borgstein P.J., et al. Reliability of intra-operative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 35 (1999) 14-18
17. Dutch National Breast Cancer Platform (NABON). Guideline for the treatment of breast cancer [document on the Internet]. Oncoline; 2007 [cited 2007 May 1]. .
18. Sandrucci S., Casalegno P.S., Percivale P., Mistrangelo M., Bombardieri E., and Bertoglio S. Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori 85 (1999) 425-434
19. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553
20. Roumen R.M., Kuijt G.P., Liem I.H., and van Beek M.W. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88 (2001) 1639-1643
21. Chung M.A., Steinhoff M.M., and Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 184 (2002) 310-314
22. Jeruss J.S., Winchester D.J., Sener S.F., et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12 (2005) 34-40
23. Torrenga H., Fabry H., van der Sijp J.R., van Diest P.J., Pijpers R., and Meijer S. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. J Surg Oncol 88 (2004) 4-7
24. Krag D.N., Anderson S.J., Julian T.B., et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8 (2007) 881-888
25. Roumen R.M., Pijpers H.J., Thunnissen F.B., and Ruers T.J. Summary of the guideline 'Sentinel node biopsy in breast cancer' Dutch Work Group 'Sentinel Node Biopsy for Breast Cancer' [Dutch]. Ned Tijdschr Geneeskd 144 (2000) 1864-1867
26. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumours. International Union against cancer (UICC). 5th ed. (1997), Wiley-Liss, New York
27. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumours. International Union against cancer (UICC). 6th ed. (2002), Wiley-Liss, New York
28. Edge S.B., Niland J.C., Bookman M.A., et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst 95 (2003) 1514-1521
29. Heuts E.M., van der Ent F.W., Hulsewé K.W., Heeren P.A., and Hoofwijk A.G. Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients. Acta Chir Belg 107 (2007) 279-283
30. Lucci A., McCall L.M., Beitsch P.D., et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25 (2007) 3657-3663
31. Veronesi U., Galimberti V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
32. Chagpar A.B., and McMasters K.M. Treatment of sentinel node-positive breast cancer. Expert Rev Anticancer Ther 6 (2006) 1233-1239
33. Greco M., Agresti R., Cascinelli N., et al. Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg 232 (2000) 1-7
34. Della Rovere G.Q., Bonomi R., Ashley S., and Benson J.R. Axillary staging in women with small invasive breast tumours. Eur J Surg Oncol 32 (2006) 733-737
35. Cserni G., Bianchi S., Vezzosi V., et al. Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis. Eur J Cancer 43 (2007) 1407-1414
36. Rahusen F.D., Torrenga H., van Diest P.J., et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 136 (2001) 1059-1063
37. Bolster M.J., Peer P.G., Bult P., et al. Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol 14 (2007) 181-189
38. Mabry H., and Giuliano A.E. Sentinel node mapping for breast cancer: progress to date and prospects for the future. Surg Oncol Clin N Am 16 (2007) 55-70
39. Meijer S., Torrenga H., and van der Sijp J.R. Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases [Dutch]. Ned Tijdschr Geneeskd 146 (2002) 942-946
40. Kuijt G.P., van de Poll-Franse L.V., Voogd A.C., Nieuwenhuijzen G.A., and Roumen R.M. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol 33 (2007) 832-837
41. Giard R.W., and Coebergh J.W. Increasingly sophisticated detection of lymph node metastases: the problem of stage migration [Dutch]. Ned Tijdschr Geneeskd 143 (1999) 1766-1771
42. van der Heiden-van der Loo M., Bezemer P.D., Hennipman A., et al. Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 32 (2006) 710-714
43. De Mascarel I., Bonichon F., Coindre J.M., and Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66 3 (1992) 523-527
44. Braun S., Cevlati B.S., Assemi C., et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 19 (2001) 1468-1475
45. Colpaert C., Vermeulen P., Jeuris W., et al. Early distant relapse in 'node-negative' breast cancer is not predicted by occult axillary lymph node metastases but by the features of the primary tumour. J Pathol 193 (2001) 442-449
46. Tjan-Heijnen V.C., Buit P., de Widt-Evert L.M., Ruers T.J., and Beex L.V. Micrometastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70 (2001) 81-88
47. Dowlatshahi K., Fan M., Snider H.C., and Habib F.A. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80 (1997) 1188-1197
48. Steinhoff M.M. Axillary node micrometastases: detection and biologic significance. Breast J 5 (1999) 325-329
49. Cote R.J., Peterson H.F., Chaiwun B., et al. Role of immunohistochemical detection of lymph node metastases in the management of breast cancer. International Breast Cancer Study Group. Lancet 354 (1999) 896-900